LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | GR_AOC |
|---|---|---|
| SK-BR-3 | A443654 | 1.2708 |
| Hs 578T | A443654 | 1.0238 |
| MCF7 | A443654 | 1.2282 |
| MDA-MB-231 | A443654 | 0.9761 |
| MCF 10A | A443654 | 0.7938 |
| BT-20 | A443654 | 1.0012 |
| Hs 578T | Afatinib | 0.1881 |
| SK-BR-3 | Afatinib | 1.1205 |
| BT-20 | Afatinib | 0.2554 |
| MCF 10A | Afatinib | 0.9528 |
| MDA-MB-231 | Afatinib | 0.3747 |
| MCF7 | Afatinib | 0.3327 |
| Hs 578T | Alpelisib | 0.1704 |
| SK-BR-3 | Alpelisib | 0.4442 |
| MDA-MB-231 | Alpelisib | 0.0780 |
| MCF 10A | Alpelisib | 0.1674 |
| BT-20 | Alpelisib | 0.4342 |
| MCF7 | Alpelisib | 0.5462 |
| SK-BR-3 | Alvocidib | 1.3211 |
| MCF7 | Alvocidib | 1.3181 |
| BT-20 | Alvocidib | 1.1891 |
| Hs 578T | Alvocidib | 1.1122 |
| MDA-MB-231 | Alvocidib | 1.2235 |
| MCF 10A | Alvocidib | 1.2235 |
| MDA-MB-231 | AT-7519 | 1.0642 |